GEM

Indian Navy Vaccines and Pharmaceuticals Tender 2025 India – HPV 9-valent, ROPIVACAINE, Ephedrine, Etomidate, Dehydroepiandrosterone 75 mg 2025

Posted

25 Oct 2025, 10:55 am

Deadline

04 Nov 2025, 12:00 pm

Value

₹85,750

Location

ERNAKULAM , KERALA

Progress

Issue25 Oct 2025, 10:55 am
Corrigendum25 Oct 2025
AwardPending
Explore all 4 tabs to view complete tender details

Quantity

724

Category

HUMAN PAPILOMA 9 VALENT VACCINE 6,11,16,18,31,33,35,52,58 , 0.5ML VIAL PER PFS

Bid Type

Two Packet Bid

Key Highlights

  • • Brand/OEM requirements: Not explicitly specified; prepare to validate supplier authorization for vaccines and medicines.
  • • Technical certifications/standards: No explicit IS/ISO standards listed; verify regulatory compliance for vaccines and anesthetics.
  • • Special conditions: Quantity variation up to 25% during contract and currency delivery extensions with a defined formula.
  • • Eligibility: No explicit years of experience or turnover; bidders should meet standard government procurement eligibility and provide typical documentation.
  • • Warranty/AMC: Not specified; confirm post-delivery support expectations in final contract.
  • • Penalties: No explicit LD mentioned; check final contract for penalties or performance bonds.
  • • Delivery/Installation: Delivery terms tied to original order dates; extended delivery time governed by a specific formula with a 30-day minimum.
  • • Submission readiness: Prepare GST, PAN, experience certificates, financials, EMD (if required), technical compliance, OEM authorizations.

Tender Overview

Indian Navy invites a procurement bid for multiple pharmaceutical products and vaccines, including INJ ROPIVACAINE 0.7MG PER ML, INJ EPHIDRINE 30MG, INJ ETOMIDATE 2MG PER ML, TAB DILOXANIDE 500MG, HUMAN PAPILLOMA 9 VALENT VACCINE (6,11,16,18,31,33,35,52,58, 0.5ML VIAL PER PFS), and CAP DEHYDROEPINADROSTERONE DHEA 75 MG TAB. Estimated value is ₹85,750.00. The contract includes a flexible quantity clause up to 25% increase/decrease with contracted rates. No start/end dates disclosed. The buyer’s terms require compliance with the option clause and adherence to delivery timelines related to order and extended periods. This is a government procurement by the Indian Navy under the Department Of Military Affairs, aimed at securing essential medical supplies. The BOQ lists six items, but specific quantities are not provided, signaling a need for bidder clarification and detailed pricing.

Technical Specifications & Requirements

  • Product names and categories identified in the tender: ROPIVACAINE, EPHEDRINE, ETOMIDATE, DILOXANIDE, HPV vaccine, DHEA.
  • Estimated value: ₹85,750.00; no EMD amount specified.
  • Delivery terms: option to adjust quantity by up to 25%; extended delivery mechanics described in terms clause.
  • Standards/Certification: not specified; bidders should verify regulatory compliance for each item (pharmaceuticals and vaccines).
  • BOQ items: total of 6 line items; exact quantities not disclosed.
  • Procurement context: government supply contract for medical formulations and vaccines intended for military use.
  • Additional terms: delivery period calculation references original vs extended periods and a minimum 30-day cap for added time; bids must comply with option clause.
  • Brand/OEM specifics: none stated explicitly; consider meeting standard pharmaceutical storage and cold-chain requirements as implied by vaccine items.
  • Quality/Testing: no explicit testing standards; bidders should prepare for standard pharmaceutical quality assurance.
  • Warranty/Service: not specified in the terms provided.

Terms, Conditions & Eligibility

  • EMD: not disclosed in the provided terms.
  • Experience/Eligibility: no explicit years or turnover required in the data provided; bidders should ensure compliance with general government tender eligibility and department norms.
  • Delivery: delivery obligation tied to original order dates with a 25% quantity option; extended delivery time calculated as (additional quantity / original quantity) × original delivery period, minimum 30 days.
  • Payment: terms are not specified in the data; bidders should seek clarification on payment terms during bid submission.
  • Documents: typical submission includes GST registration, PAN, experience certificates, financial statements; OEM authorizations may be required for specialized vaccines and medicines.
  • Penalties/Warranty: no explicit LDs or warranty terms stated; bidders should verify post-award obligations and potential penalties in the final contract.
  • Other clauses: the buyer reserves the right to alter quantity within the 25% threshold and to extend delivery accordingly; bidders must acknowledge and comply with the option Clause.

Key Specifications

  • Product/service names: INJ ROPIVACAINE 0.7MG/ML, INJ EPHIDRINE 30MG, INJ ETOMIDATE 2MG/ML, TAB DILOXANIDE 500MG, HPV 9-valent vaccine (0.5ML vial per PFS), CAP DHEA 75 MG

  • Estimated value: ₹85,750.00

  • Quantity/BOQ: 6 items; exact quantities not disclosed

  • Delivery terms: 25% quantity variation; delivery period calculations with minimum 30 days extension

  • Standards/Certification: not specified; verify regulatory compliance for each item

  • OEM/Brand: not specified; ensure pharmaceutical-grade sourcing and legality

Terms & Conditions

  • Quantity variation up to 25% at contract placement and during currency at contracted rates

  • Delivery period extension formula with minimum 30 days; original delivery period may be extended

  • No explicit EMD amount; ensure clarification on payment terms and penalties before submission

Important Clauses

Payment Terms

Payment terms are not explicitly provided; bidders should obtain exact terms during bid clarification and finalize in contract.

Delivery Schedule

Delivery must follow original order dates; extended delivery time calculated by (additional quantity / original quantity) × original delivery period, minimum 30 days.

Penalties/Liquidated Damages

No LD details provided; verify LD provisions and performance bonds in final contract.

Bidder Eligibility

  • Eligibility in line with standard government procurement for medical supplies

  • Ability to supply vaccines and controlled medicines with regulatory compliance

  • Submission of GST, PAN, and relevant experience certificates

Bill of Quantities (BOQ) 6 Items

Item # Title Description Quantity Unit Consignee Delivery (Days)
1 INJ ROPIVACCINE 0.7MG PER ML INJ ROPIVACCINE 0.7MG/ML 150 no bkverma@kochi 15
2 INJ EPHIDRINE 30MG INJ EPHIDRINE 30MG 150 no bkverma@kochi 15
3 INJ ETOMIDATE 2MG PER ML INJ ETOMIDATE 2MG/ML 90 no bkverma@kochi 15
4 TAB DILOXANIDE 500MG TAB DILOXANIDE 500MG 30 no bkverma@kochi 15
5 HUMAN PAPILOMA 9 VALENT VACCINE 6,11,16,18,31,33,35,52,58 , 0.5ML VIAL PER PFS HUMAN PAPILOMA 9 VALENT VACCINE 6,11,16,18,31,33,35,52,58 , 0.5ML VIAL PER PFS 4 vial bkverma@kochi 15
6 CAP DEHYDROEPINADROSTERONE DHEA 75 MG TAB CAP DEHYDROEPINADROSTERONE DHEA 75 MG TAB 300 no bkverma@kochi 15

AI-Powered Bidder Prediction

Companies most likely to bid

Unlock Bidder Insights

AI predictions on likely bidders

Required Documents

1

GST registration certificate

2

Permanent Account Number (PAN) card

3

Experience certificates for similar pharmaceutical or vaccine procurements

4

Financial statements (audited if available)

5

EMD/Security deposit documents (if required per final contract)

6

Technical bid documents demonstrating product compliance

7

OEM authorizations or dealer certificates for vaccines/medicines

8

Any regulatory approvals or licenses for import/distribution (if applicable)

Corrigendum Updates

1 Update
#1

Update

25 Oct 2025

Frequently Asked Questions

How to bid for the Indian Navy vaccines tender in India 2025

Bidders must meet standard government eligibility and submit GST, PAN, and financial documents; provide experience certificates for pharmaceutical procurements, OEM authorizations if required, and ensure compliance with regulatory norms for vaccines. The tender permits a 25% quantity variation and requires adherence to the specified delivery formula.

What documents are required for Indian Navy medical supplies tender

Submit GST certificate, PAN card, company financial statements, experience certificates for similar supply, EMD (if requested), technical bid detailing product compliance, and OEM authorizations for HPV vaccine and injectables. Include regulatory licenses for distribution if applicable.

What are the technical specifications for HPV 9-valent vaccine in this tender

HPV vaccine item is listed as 9-valent with 0.5ML vial per prefilled syringe; exact regulatory standards are not specified in the text, bidder should verify WHO/AYUSH approvals and Indian regulatory compliance for vaccine data sheets and cold-chain requirements.

When is the delivery period for the Indian Navy medicine tender 2025

Delivery period is tied to the original delivery order with an option to increase quantity by up to 25%; extended delivery time is calculated using the formula, with a minimum extension of 30 days if exercised.

What are the EMD requirements for the Indian Navy health procurement

EMD details are not disclosed in the tender text; bidders should request clarification during bid submission and prepare to furnish an EMD amount as specified in the final contract terms.

How to ensure regulatory compliance for vaccines in this tender in India

Obtain OEM authorizations or approvals for each vaccine and injectable, verify ISI/ISO or national standards where applicable, maintain cold-chain logistics, and provide quality assurance documents and lot-wise certificates with bid submission.

What is the estimated value and item list for the Indian Navy procurement

The estimated value is ₹85,750.00 and the six-item BOQ includes ROPIVACAINE, EPHEDRINE, ETOMIDATE, DILOXANIDE, HPV 9-valent vaccine, and DHEA 75 mg tablets; quantities are not disclosed, bidders should seek clarity on exact lot sizes.

What delivery terms apply to quantity fluctuations in this tender

The purchaser may increase/decrease the ordered quantity by up to 25% at contract initiation and during the currency; supplier must price terms accordingly and adjust production and delivery plans to meet revised orders.